
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT
- About
LMF Acquisition Opportunities Inc (ICUCW)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: ICUCW (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type Stock | Historic Profit 6.25% | Avg. Invested days 21 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta -0.86 | 52 Weeks Range 0.02 - 0.11 | Updated Date 05/24/2025 |
52 Weeks Range 0.02 - 0.11 | Updated Date 05/24/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -1304.44% |
Management Effectiveness
Return on Assets (TTM) -144.37% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 9810025 |
Shares Outstanding - | Shares Floating 9810025 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
LMF Acquisition Opportunities Inc
Company Overview
History and Background
LMF Acquisition Opportunities Inc. is a blank check company, also known as a special purpose acquisition company (SPAC). SPACs are formed to raise capital through an initial public offering (IPO) for the purpose of acquiring one or more existing operating companies. The company was likely founded in the last few years leading up to its IPO. Because it is a SPAC its background is centered around its sponsors and their expertise in identifying and merging with an operating company. Its evolution depends entirely on the target company it ultimately acquires.
Core Business Areas
- SPAC Formation: Formation of a special purpose acquisition company to raise capital through an IPO.
- Target Identification: Identifying and evaluating potential target companies for acquisition, with a focus in the financial services industry.
- Merger/Acquisition: Completing a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.
Leadership and Structure
Typically led by a management team with experience in private equity, investment banking, or the target industry. The structure consists of a board of directors and management responsible for identifying and executing the acquisition.
Top Products and Market Share
Key Offerings
- Capital Raising: Raising capital through an IPO. SPACs compete with traditional IPOs, private equity, and other funding methods. Market share is difficult to define as it depends on the overall deal volume and the specific sector the SPAC is targeting.
- Acquisition Target Selection: Identifying and acquiring a suitable target company. The competitors in this aspect are other SPACs, private equity firms, and strategic acquirers who are also looking for target companies. Market share is determined by the successful acquisition of promising companies.
Market Dynamics
Industry Overview
The SPAC market has seen cycles of boom and bust. Factors such as regulatory changes, investor sentiment, and the availability of attractive target companies influence the market. The financial services sector is currently under pressure because of increasing rates and a potential recession.
Positioning
LMF Acquisition Opportunities Inc's positioning depends on its management team's expertise, their ability to identify compelling acquisition targets, and their success in negotiating favorable terms. Its competitive advantage hinges on its sponsors and their deal sourcing abilities.
Total Addressable Market (TAM)
The TAM is the total value of all potential acquisition targets within the company's sector focus (financial services), representing billions of dollars. LMF Acquisition Opportunities Inc's positioning depends on its ability to successfully identify and acquire companies within that TAM.
Upturn SWOT Analysis
Strengths
- Experienced management team
- Capital raised through IPO
- Targeted sector expertise (Financial Services)
Weaknesses
- Dependence on finding a suitable acquisition target
- Limited operating history
- Shareholder dilution if acquisition fails
- Time constraint to complete acquisition
- Financial Services Sector is currently under pressure because of increasing rates and a potential recession
Opportunities
- Acquire undervalued companies
- Capitalize on market dislocations to find better deals
- Merging with a fast-growing Fintech company.
Threats
- Increased competition from other SPACs and private equity firms
- Regulatory changes impacting SPAC structure
- Economic downturn affecting target company valuations
- Failure to complete an acquisition within the specified timeframe
Competitors and Market Share
Key Competitors
- Other SPACs
Competitive Landscape
The competitive landscape is intense, with numerous SPACs and private equity firms seeking attractive acquisition targets. LMF Acquisition Opportunities Inc. needs to differentiate itself by leveraging its sector expertise and network.
Growth Trajectory and Initiatives
Historical Growth: No meaningful historical growth to analyze as a SPAC.
Future Projections: Future growth depends entirely on the target company acquired and its subsequent performance. Analyst estimates are tied to the projected performance of the acquired entity.
Recent Initiatives: Focus on identifying and evaluating potential acquisition targets. Any announcements regarding potential deals would be significant.
Summary
LMF Acquisition Opportunities Inc. is a SPAC focused on acquiring a target company in the financial services sector. Its success hinges on its ability to identify and merge with a strong company. Like other SPACs, it faces risks related to competition, regulatory changes, and market conditions. The management team's experience is a key asset, but the lack of an operating history and time constraints pose challenges.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC Filings
- Financial News Outlets
- Market Research Reports
Disclaimers:
The information provided is for informational purposes only and should not be considered investment advice. Investment decisions should be based on thorough research and consultation with a financial professional. Market share data is estimated and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About LMF Acquisition Opportunities Inc
Exchange NASDAQ | Headquaters Denver, CO, United States | ||
IPO Launch date 2021-03-18 | CEO, President & Executive Director Mr. Eric Schlorff | ||
Sector Healthcare | Industry Biotechnology | Full time employees 19 | Website https://seastarmedical.com |
Full time employees 19 | Website https://seastarmedical.com |
SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.